Gapicomine
Gapicomine (INN) is a coronary vasodilator. It has been withdrawn from the market in the countries it was used in.[1]
 | |
| Clinical data | |
|---|---|
| Routes of administration | oral (tablet) |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H13N3 |
| Molar mass | 199.257 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  | |
Also, gapicomine is a major component in the drug Bicordin.[2]
History
Gapicomine was discovered in 1970 by Polish chemist Stanisław Biniecki. It was first published about in an article of The Polish Journal of Medicine and Pharmacy describing the derivative drug Bicordin in 1974.[3]
gollark: ...
gollark: That sounds like nihilism.
gollark: I'm continuously amazed that people manage to control cars at 70mph on busy motorways for large periods of time with seemingly very few problematic accidents.
gollark: Your roles list doesn't say that.
gollark: So in the many worlds interpretation, do you instead get different universes where they were either funny or serious instead of them just collapsing into one state?
References
- "Gapicomine Monograph, The Index Nominum". Retrieved 2008-03-31.
- "Bicordin, PubChem". Retrieved 2008-03-31.
- Samochowiec L, Wójcicki J, Gregorczyk K, Szmatloch E (1974). "Bicordin--a new drug in the treatment of coronary heart disease". Mater Med Pol. 6 (4): 298–300. PMID 4453155.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.